Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Friday, July 11, 2014

Trillium Therapeutics: An Preclinical Cancer Immunotherapy Company With A Promising Lead Compound

Trillium Therapeutics' lead compound is SIRPI Fc, which blocks CD47, the "don't eat me" signal on cancer cells which prevents immune-mediated cancer cell killing.

http://ift.tt/1m0paG8

No comments:

Post a Comment

Popular Stem Cell Roundup Posts